Related Experiment Video

Updated: Jul 20, 2026

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
10:32

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination

Published on: August 24, 2015

The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future

Raymond P Goodrich1, Richard A Edrich, Junzhi Li

  • 1Navigant Biotechnologies Inc, Lakewood, CO 80215, USA. ray.goodrich@navigantbiotech.com

Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
|August 29, 2006
PubMed

Insights

Pathogen contamination threatens blood transfusion safety. The novel Mirasol Pathogen Reduction Technology (PRT) system, using riboflavin photochemistry, is under clinical evaluation for platelets and plasma products to enhance safety.

Area of Science:

  • Blood safety
  • Transfusion medicine
  • Infectious disease prevention

Background:

  • Blood transfusion safety remains a concern due to potential pathogen contamination (viruses, bacteria, parasites).
  • Existing methods for pathogen reduction have limitations.
  • Novel technologies are needed to improve the safety of blood products.

Purpose of the Study:

  • To review the progress and future trends of the Mirasol Pathogen Reduction Technology (PRT) system.
  • To evaluate the efficacy and safety of the Mirasol PRT system for platelets and plasma products.
  • To highlight the scientific basis of the Mirasol PRT process.

Main Methods:

  • Review of current clinical evaluation data for the Mirasol PRT system.
  • Analysis of the riboflavin photochemistry mechanism.
  • Discussion of ongoing research and development.

Main Results:

  • The Mirasol PRT system is a novel process for reducing pathogens in platelets and plasma.
  • The system utilizes riboflavin photochemistry.
  • Clinical evaluation is ongoing to confirm efficacy and safety.

Conclusions:

  • The Mirasol PRT system shows promise for enhancing blood product safety.
  • Riboflavin photochemistry offers a new approach to pathogen reduction.
  • Further research and clinical data are essential to establish the role of Mirasol PRT in transfusion medicine.

More Related Videos

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System12:40

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Published on: December 7, 2012

PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP06:36

PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP

Published on: April 9, 2013

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...